China has removed pangolin parts from its official Chinese Pharmacopoeia.
According to reports of state media on 9 June 2020, products from pangolin are officially prohibited for use in traditional Chinese medicine.
The decision was made a few days after China announced to strengthen its legal protection on the endangered animal. Pangolin, the world’s most heavily trafficked mammal, is thought by some scientists to be the possible host of the novel coronavirus that emerged at a market in China’s Wuhan city last year.
The pangolin’s body parts fetch a high price on black markets. Their scales are considered as precious medical ingredients in traditional medicine, while their meat is consumed as a delicacy in many Asian countries. China’s forestry authority has given pangolins the highest level of protection in the country due to its threatened status.
Since the outbreak of Covid-19, China has banned the sale of wild animals for food to prevent the risk of diseases spreading to humans. However, the trade of some wildlife products still remains legal for research and traditional medicine.